Amirav Lilac, Berlin Shai, Olszakier Shunit, Pahari Sandip K, Kahn Itamar
Schulich Faculty of Chemistry, Technion - Israel Institute of Technology, Haifa, Israel.
Department of Neuroscience, Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
Front Neurosci. 2019 Feb 1;13:12. doi: 10.3389/fnins.2019.00012. eCollection 2019.
The development of imaging methodologies for single cell measurements over extended timescales of up to weeks, in the intact animal, will depend on signal strength, stability, validity and specificity of labeling. Whereas light-microscopy can achieve these with genetically-encoded probes or dyes, this modality does not allow mesoscale imaging of entire intact tissues. Non-invasive imaging techniques, such as magnetic resonance imaging (MRI), outperform light microscopy in field of view and depth of imaging, but do not offer cellular resolution and specificity, suffer from low signal-to-noise ratio and, in some instances, low temporal resolution. In addition, the origins of the signals measured by MRI are either indirect to the process of interest or hard to validate. It is therefore highly warranted to find means to enhance MRI signals to allow increases in resolution and cellular-specificity. To this end, cell-selective bi-functional magneto-fluorescent contrast agents can provide an elegant solution. Fluorescence provides means for identification of labeled cells and particles location after MRI acquisition, and it can be used to facilitate the design of cell-selective labeling of defined targets. Here we briefly review recent available designs of magneto-fluorescent markers and elaborate on key differences between them with respect to durability and relevant cellular highlighting approaches. We further focus on the potential of intracellular labeling and basic functional sensing MRI, with assays that enable imaging cells at microscopic and mesoscopic scales. Finally, we illustrate the qualities and limitations of the available imaging markers and discuss prospects for neural imaging and large-scale brain mapping.
在完整动物体内,开发用于长达数周的长时间单细胞测量的成像方法,将取决于标记的信号强度、稳定性、有效性和特异性。虽然光学显微镜可以通过基因编码探针或染料实现这些目标,但这种方式无法对整个完整组织进行中尺度成像。非侵入性成像技术,如磁共振成像(MRI),在视野和成像深度方面优于光学显微镜,但不具备细胞分辨率和特异性,信噪比低,在某些情况下时间分辨率也低。此外,MRI测量的信号来源要么与感兴趣的过程间接相关,要么难以验证。因此,非常有必要找到增强MRI信号的方法,以提高分辨率和细胞特异性。为此,细胞选择性双功能磁荧光造影剂可以提供一个优雅的解决方案。荧光为MRI采集后识别标记细胞和颗粒位置提供了手段,并且可用于促进对特定目标进行细胞选择性标记的设计。在这里,我们简要回顾了磁荧光标记的最新可用设计,并详细阐述了它们在耐久性和相关细胞突出显示方法方面的关键差异。我们进一步关注细胞内标记和基本功能传感MRI的潜力,以及能够在微观和介观尺度上对细胞进行成像的检测方法。最后,我们阐述了现有成像标记的特性和局限性,并讨论了神经成像和大规模脑图谱的前景。